Roivant Sciences Ltd. (ROIV) Presents at Leerink Global Healthcare Conference 2026 Transcript

Group 1 - The company has experienced a transformative period, focusing on finding and developing impactful drugs through creative methods [4] - The CEO highlighted the successful selection of indications and the development of a robust pipeline, indicating that the efforts are now yielding positive results [4] - The company is optimistic about future prospects, having received a series of positive developments recently [5]